中外製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/05/01 | 8,325 | 8,481 | 8,258 | 8,439 | +220 | +2.7% | 1,695,800 |
| 2025/04/30 | 8,103 | 8,274 | 8,054 | 8,219 | +201 | +2.5% | 3,470,600 |
| 2025/04/28 | 8,252 | 8,269 | 7,972 | 8,018 | -256 | -3.1% | 2,641,200 |
| 2025/04/25 | 8,539 | 8,540 | 8,181 | 8,274 | +23 | +0.3% | 3,484,900 |
| 2025/04/24 | 8,100 | 8,395 | 8,069 | 8,251 | +57 | +0.7% | 2,986,200 |
| 2025/04/23 | 8,227 | 8,330 | 8,114 | 8,194 | -119 | -1.4% | 3,501,200 |
| 2025/04/22 | 8,351 | 8,367 | 8,222 | 8,313 | -107 | -1.3% | 2,705,600 |
| 2025/04/21 | 8,292 | 8,459 | 8,210 | 8,420 | +92 | +1.1% | 3,276,400 |
| 2025/04/18 | 8,065 | 8,427 | 7,897 | 8,328 | +1,243 | +17.5% | 10,232,300 |
| 2025/04/17 | 6,826 | 7,085 | 6,804 | 7,085 | +332 | +4.9% | 2,687,900 |
| 2025/04/16 | 6,694 | 6,753 | 6,639 | 6,753 | +115 | +1.7% | 1,665,700 |
| 2025/04/15 | 6,674 | 6,752 | 6,605 | 6,638 | +36 | +0.5% | 1,393,200 |
| 2025/04/14 | 6,380 | 6,697 | 6,360 | 6,602 | +316 | +5% | 2,393,000 |
| 2025/04/11 | 6,384 | 6,451 | 6,232 | 6,286 | -432 | -6.4% | 3,678,900 |
| 2025/04/10 | 6,759 | 6,804 | 6,631 | 6,718 | +359 | +5.6% | 2,542,800 |
| 2025/04/09 | 6,450 | 6,508 | 6,291 | 6,359 | -183 | -2.8% | 2,551,100 |
| 2025/04/08 | 6,585 | 6,627 | 6,425 | 6,542 | +150 | +2.3% | 2,640,300 |
| 2025/04/07 | 6,554 | 6,640 | 6,287 | 6,392 | -262 | -3.9% | 3,343,100 |
| 2025/04/04 | 6,631 | 6,930 | 6,569 | 6,654 | +26 | +0.4% | 3,146,000 |
| 2025/04/03 | 6,385 | 6,679 | 6,380 | 6,628 | +43 | +0.7% | 2,713,500 |
| 2025/04/02 | 6,714 | 6,758 | 6,546 | 6,585 | -203 | -3% | 1,720,100 |
| 2025/04/01 | 6,816 | 6,889 | 6,752 | 6,788 | -11 | -0.2% | 1,574,700 |
| 2025/03/31 | 6,812 | 6,866 | 6,746 | 6,799 | -243 | -3.5% | 2,669,900 |
| 2025/03/28 | 7,003 | 7,059 | 6,945 | 7,042 | +3 | ±0% | 1,856,100 |
| 2025/03/27 | 7,006 | 7,137 | 7,006 | 7,039 | -52 | -0.7% | 2,072,900 |
| 2025/03/26 | 7,046 | 7,183 | 7,021 | 7,091 | +55 | +0.8% | 2,416,900 |
| 2025/03/25 | 7,048 | 7,085 | 6,957 | 7,036 | +115 | +1.7% | 1,494,600 |
| 2025/03/24 | 7,007 | 7,014 | 6,896 | 6,921 | +45 | +0.7% | 1,460,200 |
| 2025/03/21 | 6,752 | 6,967 | 6,752 | 6,876 | +140 | +2.1% | 3,373,300 |
| 2025/03/19 | 6,820 | 6,860 | 6,731 | 6,736 | -93 | -1.4% | 2,303,900 |
| 2025/03/18 | 6,931 | 6,962 | 6,809 | 6,829 | -33 | -0.5% | 2,250,600 |
| 2025/03/17 | 6,981 | 6,996 | 6,862 | 6,862 | -19 | -0.3% | 1,208,400 |
| 2025/03/14 | 6,803 | 6,956 | 6,757 | 6,881 | +4 | +0.1% | 3,223,200 |
| 2025/03/13 | 6,956 | 7,047 | 6,877 | 6,877 | -61 | -0.9% | 2,408,600 |
| 2025/03/12 | 6,814 | 7,038 | 6,814 | 6,938 | +153 | +2.3% | 2,604,600 |
| 2025/03/11 | 6,511 | 6,801 | 6,472 | 6,785 | +78 | +1.2% | 3,277,600 |
| 2025/03/10 | 6,924 | 6,967 | 6,666 | 6,707 | -256 | -3.7% | 2,700,800 |
| 2025/03/07 | 7,071 | 7,112 | 6,911 | 6,963 | -389 | -5.3% | 3,187,300 |
| 2025/03/06 | 7,423 | 7,492 | 7,352 | 7,352 | -158 | -2.1% | 1,896,400 |
| 2025/03/05 | 7,418 | 7,553 | 7,338 | 7,510 | +83 | +1.1% | 1,727,300 |
| 2025/03/04 | 7,581 | 7,618 | 7,382 | 7,427 | -194 | -2.5% | 3,104,300 |
| 2025/03/03 | 7,787 | 7,787 | 7,606 | 7,621 | +134 | +1.8% | 1,813,200 |
| 2025/02/28 | 7,555 | 7,702 | 7,456 | 7,487 | -201 | -2.6% | 3,812,100 |
| 2025/02/27 | 7,916 | 7,949 | 7,664 | 7,688 | -210 | -2.7% | 2,475,400 |
| 2025/02/26 | 7,900 | 7,979 | 7,820 | 7,898 | +32 | +0.4% | 2,509,600 |
| 2025/02/25 | 7,710 | 7,895 | 7,710 | 7,866 | +181 | +2.4% | 3,071,400 |
| 2025/02/21 | 7,500 | 7,705 | 7,484 | 7,685 | +329 | +4.5% | 3,520,300 |
| 2025/02/20 | 7,307 | 7,356 | 7,146 | 7,356 | -44 | -0.6% | 1,851,200 |
| 2025/02/19 | 7,385 | 7,410 | 7,300 | 7,400 | -4 | -0.1% | 1,366,100 |
| 2025/02/18 | 7,350 | 7,423 | 7,217 | 7,404 | +17 | +0.2% | 1,315,100 |
1～
50
件表示中 / 3691件
類似銘柄と比較する
現在ご覧いただいている「中外薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 中外薬 | 843,900円 | +1.7% | +5.0% | 2.96% | 33.87倍 | 7.30倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
| 第一三共 | 365,500円 | +6.0% | +4.0% | 2.13% | 22.69倍 | 4.19倍 |
|
国内製薬大手。循環器と感染症薬強い。英アストラゼネカ社と提携し、がん領域の開拓中 |
| 武 田 | 437,200円 | +7.7% | +206.9% | 4.48% | 58.47倍 | 0.99倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 731,500円 | +2.2% | +10.2% | 1.64% | 14.05倍 | 1.41倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| アステラス薬 | 143,900円 | +0.9% | +380.2% | 5.42% | 19.82倍 | 1.70倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
市場注目の銘柄
チャート関連のコラム
